XML 27 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Note 2 - Earnings Per Share
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Earnings Per Share [Text Block]
Note
2.
Earnings Per Share
 
There are
no
convertible securities which would affect the numerator in calculating basic and diluted earnings per share; therefore, net income as presented on the Consolidated Statement of Income is used as the numerator.
 
The following table sets forth the composition of the weighted-average common shares (denominator) used in the basic and diluted earnings per share computation.
 
    Three Months Ended
    March 31,
    2020   2019
(Dollars in thousands, except share and per share data)        
         
Net income   $
773
    $
2,925
 
                 
Weighted-Average Basic Common Shares Outstanding    
5,431,199
     
5,432,856
 
Dilutive Effect of Common Stock Equivalents (Stock Options and Restricted Stock)    
25,668
     
18,622
 
Weighted-Average Diluted Common Shares and Common Stock Equivalents Outstanding    
5,456,867
     
5,451,478
 
                 
Earnings per share:                
Basic   $
0.14
    $
0.54
 
Diluted    
0.14
     
0.54
 
 
The dilutive effect on weighted average diluted common shares outstanding is the result of outstanding stock options and nonvested restricted stock. For the
three
months ended
March 31, 2020
and
2019,
options to purchase
78,545
and
83,688
shares of common stock, respectively, were outstanding but were
not
included in the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares for the period, therefore the effect would be antidilutive. For the
three
months ended
March 31, 2020,
30,250
shares of restricted stock awards were
not
included in the computation of diluted earnings per share because the hypothetical repurchase of shares under the treasury stock method exceeded the weighted average nonvested restricted awards, therefore the effect would be anti-dilutive. For the
three
months ended
March 31, 2019,
there were
no
anti-dilutive restricted stock awards.